| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2021 | Kim Austin D.66 | EVP &General Counsel | Sale+OE | 678 | $53.34 | $36,164.52 | -10.9% | |
| Jan 6, 2021 | Ridloff Elena48 | EVP And CFO | Sale+OE | 1,016 | $53.34 | $54,193.44 | -20.7% | |
| Jan 6, 2021 | Davis Stephen68 | CEO | Sale+OE | 3,484 | $53.34 | $185,836.56 | -12.5% | |
| Nov 20, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 2,728 | $53.50 | $145,948.00 | -14.2% | |
| Oct 27, 2020 | Kim Austin D.66 | EVP &General Counsel | Sale+OE | 8,750 | $45.10 | $394,636.38 | -69.4% | |
| Oct 16, 2020 | Yang Michael J. | EVP And CCO | Sale+OE | 1,247 | $42.56 | $53,072.32 | -16.2% | |
| Oct 16, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 1,297 | $42.56 | $55,200.32 | -9.1% | |
| Oct 16, 2020 | Davis Stephen68 | CEO | Sale+OE | 2,960 | $42.56 | $125,977.60 | -16.7% | |
| Jul 7, 2020 | Yang Michael J. | EVP And CCO | Sale+OE | 27,250 | $56.25 | $1,532,786.37 | -55.9% | |
| Jun 19, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 82,295 | $50.03 | $4,117,244.43 | -78.4% |